EDC and ePRO Market Overview and Outlook

Report Overview

The pharmaceutical industry has typically been slow to adopt new data collection technology when it comes to clinical development. And to some degree this is understandable when you are working in a highly regulated industry where patient safety is the highest priority. Why change a proven process?

However, over the past decade we have witnessed the industry’s almost total acceptance of electronic data capture (EDC) technology and the growing acceptance of electronic patient reported outcomes (ePRO) applications.

In this report, Primary Investigators and Site Coordinators provide their satisfaction with product attributes, such as human-machine interface, technical support, EDC page load speed, etc.

What you will learn:

For Sponsors and CROs:

• Understand how to select a technology partner that enhances your relationships with sites
• Identify and avoid study types users believe are least suited for the technologies
• Anticipate future adoption estimates for ePRO technologies
• Learn which technology providers have the best and worst integration capabilities with other technologies

For Technology Providers:

• Understand your own brand’s strength vs. competing providers Technology users’ brand preferences
• Receive detailed performance profiles for many major technology providers across critical success factors
• Identify competitive strengths and weaknesses and product satisfaction profiles across all major brands
• Technology users’ brand preferences

Report Contents:

1. High-level takeaways and implications: In this section we lay out what the data in this report is telling us and how it could impact your development strategies and operations. The goal of this section is to arm you with usable recommendations that can impact your current and future operations.
2. EDC service provider section: This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Data Capture. These include adoption and preference for EDC as well as service provider brand leadership and performance.
3. ePRO service provider section: This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Patient Reported Outcomes. These include
4. adoption and preference for ePRO as well as service provider brand leadership and performance
5. Trends and ideas impacting clinical development: In the end a sponsor or service provider wants to lock patient data on-time. This section ties together respondents’ views of how these technologies can and could improve the speed of and general conduct of clinical development studies.